KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Elena Vendramini, Riccardo Bomben, Federico Pozzo, Dania Benedetti, Tamara Bittolo, Francesca Maria Rossi, Michele Dal Bo, Kari G. Rabe, Gabriele Pozzato, Francesco Zaja, Annalisa Chiarenza, Francesco Di Raimondo, Esteban Braggio, Sameer A. Parikh, Neil E. Kay, Tait D. Shanafelt, Giovanni Del Poeta, Valter Gattei, Antonella Zucchetto

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival'. Together they form a unique fingerprint.